TY - JOUR
T1 - Generation and characterization of human induced pluripotent stem cell (iPSC) lines from two asymptomatic Greek carriers of the Phospholamban (PLN)-R14del pathogenic variant and a non-carrier relative
AU - Gaar-Humphreys, Karen R
AU - Balducci, Valentina
AU - Pol, Femke
AU - Vafiadaki, Elizabeth
AU - Anastasakis, Aris
AU - Kolokathis, Fotis
AU - Sanoudou, Despina
AU - Doevendans, Pieter
AU - Sluijter, Joost P G
AU - Stillitano, Francesca
N1 - Publisher Copyright:
© 2025 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
PY - 2025/12
Y1 - 2025/12
N2 - Phospholamban (PLN) cardiomyopathy, caused by the deletion of arginine 14 in PLN (PLN-R14del), is associated with both dilated and arrhythmogenic cardiomyopathy, often manifesting early in life. Interestingly, some carriers remain asymptomatic with a normal life span. The mechanisms underlying disease progression remain unclear. We generated human induced pluripotent stem cell (iPSC) lines from peripheral blood mononuclear cells of two asymptomatic Greek PLN-R14del carriers and one non-carrier relative. These iPSC lines exhibit typical morphology and markers of undifferentiated hPSC state, providing an in vitro platform to investigate disease mechanisms and gain insights into the patient-specific onset and progression of PLN-R14del cardiomyopathy.
AB - Phospholamban (PLN) cardiomyopathy, caused by the deletion of arginine 14 in PLN (PLN-R14del), is associated with both dilated and arrhythmogenic cardiomyopathy, often manifesting early in life. Interestingly, some carriers remain asymptomatic with a normal life span. The mechanisms underlying disease progression remain unclear. We generated human induced pluripotent stem cell (iPSC) lines from peripheral blood mononuclear cells of two asymptomatic Greek PLN-R14del carriers and one non-carrier relative. These iPSC lines exhibit typical morphology and markers of undifferentiated hPSC state, providing an in vitro platform to investigate disease mechanisms and gain insights into the patient-specific onset and progression of PLN-R14del cardiomyopathy.
U2 - 10.1016/j.scr.2025.103865
DO - 10.1016/j.scr.2025.103865
M3 - Article
C2 - 41176972
SN - 1873-5061
VL - 89
JO - Stem Cell Research
JF - Stem Cell Research
M1 - 103865
ER -